ISOTRETINOIN MEDICATION PROGRAM ALERTING RISKS OF TERATOGENICITY Trademark
Trademark Overview
On Tuesday, July 16, 2002, a trademark application was filed for ISOTRETINOIN MEDICATION PROGRAM ALERTING RISKS OF TERATOGENICITY with the United States Patent and Trademark Office. The USPTO has given the ISOTRETINOIN MEDICATION PROGRAM ALERTING RISKS OF TERATOGENICITY trademark a serial number of 78144310. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, July 21, 2003. This trademark is owned by RANBAXY LABORATORIES LIMITED. The ISOTRETINOIN MEDICATION PROGRAM ALERTING RISKS OF TERATOGENICITY trademark is filed in the Paper & Printed Material Products and Computer & Software Services & Scientific Services categories with the following description:
printed instructional and educational materials used for counseling doctors to provide patients with information on the importance of pregnancy prevention while undergoing treatment with a pharmaceutical preparation associated with fetal abnormalities
counseling to doctors to provide patients with information on the importance of pregnancy prevention while undergoing treatment with a pharmaceutical preparation associated with fetal abnormalities
General Information
| Serial Number | 78144310 |
| Word Mark | ISOTRETINOIN MEDICATION PROGRAM ALERTING RISKS OF TERATOGENICITY |
| Filing Date | Tuesday, July 16, 2002 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Monday, July 21, 2003 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | printed instructional and educational materials used for counseling doctors to provide patients with information on the importance of pregnancy prevention while undergoing treatment with a pharmaceutical preparation associated with fetal abnormalities |
| Goods and Services | counseling to doctors to provide patients with information on the importance of pregnancy prevention while undergoing treatment with a pharmaceutical preparation associated with fetal abnormalities |
Classification Information
| International Class | 016 - Paper, cardboard and goods made from these materials, not included in other classes; printed matter; bookbinding material; photographs; stationery; adhesives for stationery or household purposes; artists' materials; paint brushes; typewriters and office requisites (except furniture); instructional and teaching material (except apparatus); plastic materials for packaging (not included in other classes); printers' type; printing blocks. |
| US Class Codes | 002, 005, 022, 023, 029, 037, 038, 050 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, July 20, 2002 |
| Primary Code | 016 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, July 20, 2002 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | RANBAXY LABORATORIES LIMITED |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | New Delhi 110 019
IN |
Trademark Events
| Event Date | Event Description |
| Monday, July 21, 2003 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Tuesday, November 19, 2002 | NON-FINAL ACTION MAILED |
| Tuesday, November 12, 2002 | ASSIGNED TO EXAMINER |
| Friday, August 30, 2002 | TEAS VOLUNTARY AMENDMENT RECEIVED |
